首页> 外文期刊>Leukemia and lymphoma >NPM-RAR, not the RAR-NPM reciprocal t(5;17)(q35;q21) acute promyelocytic leukemia fusion protein, inhibits myeloid differentiation
【24h】

NPM-RAR, not the RAR-NPM reciprocal t(5;17)(q35;q21) acute promyelocytic leukemia fusion protein, inhibits myeloid differentiation

机译:NPM-RAR,而不是RAR-NPM相互的t(5; 17)(q35; q21)急性早幼粒细胞白血病融合蛋白,可抑制骨髓分化

获取原文
获取原文并翻译 | 示例
           

摘要

The t(5;17) variant of acute promyelocytic leukemia (APL) fuses the nucleophosmin (NPM) gene at 5q35 with the retinoic acid receptor alpha (RARA) at 17q12-22. We have previously shown that leukemic cells express both NPM-RAR and RAR- NPM reciprocal translocation products. In this study we investigated the potential role of both proteins in modulating myeloid differentiation. Expression of NPM-RAR inhibited vitamin D3/transforming growth factor β (TGFβ)-mediated differentiation of U937 cells by more than 50%. In contrast, RAR-NPM expression did not alter vitamin D3/TGFβ-induced differentiation of U937 clones. These results indicate that NPM-RAR, not RAR-NPM, is the prime mediator of myeloid differentiation arrest in t(5;17) APL.
机译:急性早幼粒细胞白血病(APL)的t(5; 17)变体将5q35的核磷蛋白(NPM)基因与17q12-22的视黄酸受体α(RARA)融合在一起。先前我们已经表明,白血病细胞表达NPM-RAR和RAR-NPM相互易位产物。在这项研究中,我们调查了两种蛋白质在调节髓样分化中的潜在作用。 NPM-RAR的表达抑制了维生素D3 /转化生长因子β(TGFβ)介导的U937细胞分化超过50%。相反,RAR-NPM表达不会改变维生素D3 /TGFβ诱导的U937克隆的分化。这些结果表明NPM-RAR,而不是RAR-NPM,是t(5; 17)APL中髓样分化停滞的主要介体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号